From professional translators, enterprises, web pages and freely available translation repositories.
ravim sisaldab toimeainena tsertolisumab- pegooli.
it contains the active substance certolizumab pegol.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
rahvusvaheline mittekaubanduslik nimetus (inn): tsertolisumab- pegool
international non-proprietary name (inn): certolizumab pegol
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
cimzias on tsertolisumab pegüleeritud (kinnitatud keemilise aine polüetüleenglükooli külge).
in cimzia, certolizumab has been ‘ pegylated’ (attached to a chemical called polyethylene glycol).
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
eeldati, et tnf- α blokeerimisega leevendab tsertolisumab põletikku ja haiguse muid sümptomeid.
by blocking tnf-alpha, certolizumab was expected to improve the inflammation and other symptoms of the disease.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
cimzias toimeainena sisalduv tsertolisumab- pegool on immunosupressant (immuunvastust vähendav ravim).
the active substance in cimzia, certolizumab pegol, is an immunosuppressant medicine.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
tsertolisumab seondub spetsiifiliselt organismis sisalduva virgatsaine – kasvaja α- nekroositeguriga (tnf- α).
certolizumab has been designed to bind to a chemical messenger in the body called tumour necrosis factor-alpha (tnf-alpha).
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
